Legal Representation
Attorney
Steven A. Abreu
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 12, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Mar 12, 2020 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Mar 12, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Feb 10, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Aug 30, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 30, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 30, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Aug 30, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jun 25, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Jun 22, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 13, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
house mark for pharmaceutical preparations
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of three intersecting curved shapes in the colors orange, light purple and blue, to the left of the words Sage Therapeutics, where Sage appears above the word Therapeutics.
Color Claim
The color(s) orange, light purple and blue is/are claimed as a feature of the mark.
Classification
International Classes
005